light methods have all been laboratory tested, and to varying extents, clinically evaluated to assess their efficacy for environmental decontamination. This review article considers these different decontamination technologies, discussing their mechanism of action, antimicrobial efficacy and advantages and limitations, with a view to providing the reader with a comprehensive overview of the technological advances being developed to reduce the levels of environmental contamination around patient areas, thus aiding in the fight against healthcare-associated infection.
The importance of environmental decontamination
Microbiological contamination of the clinical environment is increasingly being highlighted as a source of infection, with direct contact with contaminated surfaces, indirect contact with contaminated surfaces via the hands of medical staff or equipment, and the air; all being recognised as potential sources of cross infection [1] [2] [3] . High standards of cleaning and disinfection will contribute to minimising the risk of infection and have been shown to play an important role in controlling outbreaks of infection [4, 5] .
The hospital environment can quickly become contaminated and act as a reservoir for infection, and evidence shows that significant contamination of nurse's hands can occur from contact with environmental surfaces in the patient's environment [2, [6] [7] [8] .
Frequently touched sites, such as door handles, light switches, bed tables and bed rails, are thought to provide the greatest potential risk for cross infection [9] . Previous studies have demonstrated that healthcare workers' hands can become contaminated through contact with inanimate objects or intact patient skin surfaces, and they can subsequently transfer organisms to other surfaces within the room and potentially to other patients [7] . Indeed, healthcare workers are almost as likely to contaminate their hands after only touching environmental surfaces in the room as they are when they touch both the patient and environmental surfaces [8] .
Environmental cleaning using disinfectants is essential for reducing contamination; however, ensuring that the level of cleaning which occurs is adequate can be an issue. Studies have shown that flat surfaces, such as bedside tables and locker tops, are cleaned more often than small vertical surfaces such as door handles and light switches [10, 11] , but also, there are surfaces within the room, such as walls and electronic equipment, which are not routinely cleaned but can still harbour potential pathogens. Another issue is that there can be uncertainty amongst staff about who has the responsibility for cleaning patient-related surfaces and medical equipment [9, 10] . In addition to these difficulties, organisms such as MRSA, C. difficile, Acinetobacter and vancomyion-resistant enterococci (VRE) can persist on surfaces in the hospital environment-even after discharge cleaning-for significant periods of time, facilitating their transmission between patients, staff and the environment [9, 12••] .
As a consequence of these issues, there has been an upsurge of interest in the development of new 'wholeroom' environmental decontamination technologies [12••, 13, 14] which can supplement the standard cleaning and infection control procedures currently in place, with the aim of providing enhanced hygiene and a safer patient environment. This review provides a discussion of a number of the key technologies currently under development for this purpose.
Gaseous decontamination methods
The use of gaseous decontamination, also known as 'chemical fogging', within clinical settings, has emerged as an adjunct measure for inactivation of microorganisms. Gaseous decontamination is a method where either a mist or vapour form of a chemical disinfectant is applied to promote whole room decontamination. Most typically, the use of hydrogen peroxide, chlorine dioxide and ozone has been investigated due to their broad antimicrobial spectra.
Gaseous decontamination presents advantages including the dissipation of gaseous disinfectants allowing decontamination of large, difficult to reach areas, which may be missed or neglected by manual cleaning [12••] . However, despite this, several limitations are associated with this method of decontamination, particularly the rapid recontamination of rooms within days of reoccupancy, therefore making them more suited to terminal cleaning procedures to provide a deep clean of the room before the next patient is admitted. A range of gaseous technologies will be discussed in the following sections, and Table 1 provides a summary of the advantages and considerations of the use of gaseous technologies and the other technologies discussed later in this review.
Hydrogen peroxide
Hydrogen peroxide (H 2 O 2 ) is an oxidising agent used to decontaminate surfaces and objects within hospital rooms and wards. H 2 O 2 has a broad spectrum of activity against clinically relevant bacteria, bacterial endospores and viruses [15] [16] [17] [18] [19] , and once decomposed, does not pose any toxic threat to the environment by forming nontoxic by-products of water and oxygen [20] . The mechanism of antimicrobial activity is thought to involve oxidative damage to Aerosolised systems include the commercially available ASP Glosair (formally known as Sterinis) and Oxypharm Nocospray. These systems deliver a pressure-generated fine mist aerosol of H 2 O 2 , and the recommended dose for hospitals is 6 ml/m 3 per cycle, during which electrically charged particles circulate in the air, adhere to microbes in the air and on surfaces, inactivating them [15, 16] . Following the decontamination cycle, no aeration systems are required to remove the H 2 O 2 as it naturally decomposes (unlike H 2 O 2 vapour systems) [21••] .
Clinical testing has been proven successful, with a study by Barbut et al. [15] demonstrating the ability of aHP to decontaminate surfaces in hospitals. There was a 91 % decrease in contamination of various surfaces within hospital rooms previously occupied by a C. difficile infected patient, compared to a 50 % decrease using conventional cleaning with 0.5 % sodium hypochlorite [15] . More recently, the efficacy of an aHP system was tested against clinical isolates from American hospital patients, and 93-log 10 reductions of the microorganisms were achieved [22] . The authors concluded that these results indicate that aHP could be beneficial in the clinical setting and, due to its ease of use, its low cost and the fact that the aerosol decomposes naturally, may make it easier to use than HPV [15, 22] .
Despite some beneficial features of aHP, HPV has generally been found to have greater efficacy against a range of nosocomial pathogens. Fu et al. [23•] demonstrated that HPV had greater efficacy and diffusion than aHP and achieved at least 2-log 10 greater inactivation of C. difficile, MRSA and A. baumannii over and above the level of inactivation achieved using aHP. The vapour systems generate a 30-35 % w/w vapour of hydrogen peroxide through a high-velocity air stream, with a dose of 10 g/m 3 recommended per cycle [16, 23•] . Well-documented vapour systems include Steris VHP and Bioquell HPV, with other systems including PEA hydrogen peroxide gas generator and hygiene solutions IC4 system. The Steris VHP system produces non-condensing vapourised hydrogen peroxide, at a constant concentration, which does not condense onto surfaces as the air is continually dried [16, 24] . In contrast, the Bioquell system fills the air with hydrogen peroxide vapour , and the vapour subsequently condenses onto surfaces [16] . Both systems are controlled remotely from outside the room, and unlike aHP, HPV systems have an aeration unit, as active catalytic conversion is required to aid decomposition of the hydrogen peroxide into nontoxic by-products [18] .
Boyce et al. [25] documented the significant reduction in incidence of C. difficile associated disease (CDAD) due to HPV terminal cleaning. Comparing the acquisition of CDAD when the epidemic strain NAP1 was present, the study demonstrated a 53 % decrease in cases after implementation of this technology for terminal cleaning [25] . More recently, it has been shown that the use of HPV for decontamination of rooms previously occupied by a patient infected with, or carrying, a multidrug-resistant organism (MDRO), reduced the risk of the next occupant acquiring a MDRO by 64 % [26] . Furthermore, Chmielarczyk et al. [27] found the use of HPV could control an outbreak of A. baumannii in conjunction with good infection control practice, demonstrating the benefit of hydrogen peroxide vapour used during outbreaks.
Several other considerations should be taken into account before the implementation of H 2 O 2 technologies for terminal room decontamination. H 2 O 2 has wide antimicrobial efficacy; however, recent data suggests that Geobacillus stearothermophilus spores, which are used as a biological indicator of system efficacy, proved to be easier to inactivate than MRSA, therefore possibly indicating that the assumed microbial efficacy of H 2 O 2 , due to inactivation of a biological indicator, may not be automatically transferred to other organisms, and further testing may be required to establish the efficacy of H 2 
Chlorine dioxide
Chlorine dioxide is an Environmental Protection Agency (EPA) registered sterilizer, which is being increasingly investigated as a method of clinical decontamination. Previous research has demonstrated the use of ClO 2 for whole facility decontamination, with gaseous ClO 2 utilised for decontamination in the wake of a Bacillus anthracis attack on a federal building in 2001 [31] . Much in vitro work has demonstrated extensive antimicrobial properties, with laboratory studies highlighting bactericidal and fungicidal properties [32] . A study by Wilson et al. [33] demonstrated complete inactivation of Stachybotrys chartarum, Penicillium chrysogenum and Cladosporium cladosporioides fungal spores (6 log 10 population) following 24-h treatment, demonstrating 100 % treatment efficacy at both 500 and 1000 ppm. Similarly, another study highlighted significant reductions of Bacillus spores, with between 2.7 and 5.9 log 10 reductions recorded depending on the exposed surface material [34] .
Currently, there are limited studies investigating the use of ClO 2 for whole room decontamination. A recent study by Lowe et al. [35] investigated decontamination of a hospital room. A selection of common nosocomial bacterial species was transferred onto 10 sites throughout the hospital room, and the room was sealed to prevent gas leakage. Following six cycles of ClO 2 , results demonstrated between 7-and 10-log 10 reductions of all bacteria tested.
Despite extensive antimicrobial properties, a number of significant limitations have been associated with ClO 2 gas including explosive properties, thus limiting commercial storage. Furthermore, the ability to degrade and discolour certain materials limits whole room applications. Also, logistic problems are a major concern, since rooms need to be vacated and securely sealed to ensure no patient or staff exposure due to the potential for ClO 2 to cause respiratory irritations.
Ozone
Ozone is a strong oxidising agent used for inactivation of vegetative bacterial cells; however, it has shown less efficacy against resilient bacterial spores and fungi [12••, 36, 37] . Despite extensive in vitro research, there are only a limited number of studies investigating ozone within clinical environments.
A study by Doan et al. [38] compared the efficacy of eight disinfection technologies, including ozone, for decontamination of hospital isolation rooms contaminated with C. difficile. Empty isolation rooms were manually cleaned and artificially contaminated with C. difficile spores; however, results demonstrated only a 1.3-log 10 reduction following treatment with 25 ppm ozone for 142 min.
In order to enhance the antimicrobial efficacy of ozone, increased concentrations are required. However, this poses a significant toxicity hazard and potential risk of respiratory irritation. Whilst the use of ozone has been described as a relatively cheap method of decontamination, Doan et al. [38] evaluated the cost of multiple decontamination methods, highlighting ozone as the most expensive, at £116 per use; therefore, ozone generation would need to be made more cost-effective before it can be utilised widely throughout clinical environments.
Steam cleaning
The use of steam cleaning within hospital settings has generated much interest over recent years, with efficacy demonstrated against a wide spectrum of nosocomial pathogens [12••, 39, 40] . Steam can be used as an alternative to chemical disinfection where disadvantages include human hazard, microbial resistance and extensive treatment times.
Steam cleaning, as with most other decontamination technologies, presents limitations, such as steam dissipating into water presenting problems with electrical machinery and slip hazards [12••, 39] . However, a recent study by Tanner et al. [39] demonstrated the use of saturated steam cleaning. This method provides hotter but drier steam, meaning it does not pose issues with decontamination of electronic-based equipment. However, increased temperature does introduce potential scalding hazards; consequently, increased precaution should be exercised.
Following artificial inoculation onto sample surfaces, results demonstrated complete inactivation of a range of bacteria, fungi and viruses following only 5-s treatment [39] . A later study by Sexton et al. [40] investigated the reduction of microbial load in four separate hospital rooms following treatment with a portable saturated steam vapour system, with results demonstrating up to 2-log 10 reduction following only 10-20-s treatment. Although extensively employed within clinical settings, further in situ studies are required to evaluate the efficacy of this system for viral and fungal decontamination.
Light-based decontamination methods
The widespread germicidal properties of light, specifically ultraviolet (UV) light, have long been known, and UV germicidal irradiation (UVGI) has been successfully utilised for various clinical antimicrobial applications. The most germicidal wavelengths of light fall within the UVC region (240-260 nm) and UVC have been traditionally used for disinfection, particularly for air and medical device decontamination applications [41, 42] . UVC light has extremely broad antimicrobial activity, inactivating bacteria, endospores, fungi and viruses, with its action due to the absorption of UVC photons by DNA and RNA base pairs, which subsequently causes the formation of thymine dimers and other mutations, halting microbial replication [43] [44] [45] .
More recent advancements in light technologies for infection control have involved the clinical application of continuous and pulsed UV light for 'whole room' decontamination and also the increasing knowledge and application of the antimicrobial properties of violet-blue visible light. Details of these technologies are provided below.
Continuous UV light for whole-room decontamination
Decontamination using continuous UVC light typically uses systems which employ either a monochromatic low-pressure mercury lamp at 254 nm or a polychromatic medium-pressure mercury lamp. UVC light has extensive antimicrobial properties, with bacteria, fungi, viruses and protozoan organisms all demonstrating susceptibility, and this broad, efficient action has led to the selection of UVC for use in many decontamination systems [41, 42, 46••, 47] . There are currently several commercially available continuous UVC devices undergoing clinical trials for hospital decontamination, many of which are automatic non-touch disinfection systems, ensuring operator safety.
One such system is the Tru-D SmartUVC room decontamination device which utilises continuous-wave UV light (CW-UV) (254 nm range) to eradicate pathogens. This device is activated by a wireless remote control with motion sensing technology and delivers a dose between 12,000 and 36,000 μWs/cm 2 for destruction of vegetative and bacterial spores, respectively
The device is placed in the centre of the room, and operators control the technology wirelessly from an external location. Several studies have investigated the efficacy of Tru-D UVC for disinfection of various nosocomial pathogens within the laboratory and clinical environment. Boyce et al. [47] reported a 1.7-2.9-log 10 reduction in C. difficile spores following inoculation onto stainless steel carrier disks. A further study demonstrated a dosedependent 2-4-log 10 reduction of MRSA, C. difficile and VRE using the same system [46••] . Towards application for terminal cleaning, it was reported that following traditional terminal cleaning of a room after discharge of MRSA positive patients, 18 % of site tested positive for MRSA; however, following Tru-D disinfection, this was reduced to 0 % [46••].
Pulsed UV light for whole-room decontamination
Recent work has focused on the use of pulsed, polychromatic xenon flashlamps for microbial inactivation, as this technology enables rapid energy delivery and wide antimicrobial activity, whilst being more environmentally friendly than CW-UV lamps as they do not contain mercury [48] [49] [50] . Using this technology, Xenex has developed fully automated robotic decontamination systems for clinical room decontamination applications and have been marketed as 'GermZapping Robots'™. Pulsed xenon UV (PX-UV) emits intense broad spectrum light, rich in UVC wavelengths in short, high energy pulses, providing rapid decontamination, much faster than that achieved with continuous UV light. This device has a sporicidal setting of 5 min in each position, with a typical patient room taking three positions. The PX-"UV system produces a pulsed flash at a frequency of 1.5 Hz with an approximate output of 505 J per pulse and a pulse duration of less than" 360 μs [51•] . Clinical testing has demonstrated that when combined with terminal cleaning, the PX-UV disinfection system had the ability to achieve a 100 % reduction in positive cultures of VRE [52•] . Furthermore, a recent study by Levin and colleagues reported that three 7-min exposures of PX-UV following terminal cleaning contributed to a 53 % reduction in the hospital acquired C. difficile infections [51•] .
Overall, when looking at both pulsed and continuous UVC decontamination technologies, it can be seen that they offer a number of potential advantages, including their reliability and ease of usability, and importantly, the rapid biocidal activity of UVC against a wide range of healthcare-associated pathogens. However, as is the case with the chemical-based technologies, UVC technologies are also restricted for use for terminal cleaning of vacated rooms due, in this case, to the carcinogenic and mutagenic nature of UVC light [53] . Additionally, with UV technologies, there is a limited capacity to decontaminate larger rooms due to light dissipation; similarly, as many objects may be out with the direct line of site, reduced inactivation on indirectly exposed sites may be experienced [54] ; therefore, multiple cycles must be conducted, leaving system operation open to potential human error, as operators must choose appropriate locations thereby requiring more operator time. An issue for future consideration is the degradative effects of long-term UVC exposure on hospital materials and equipment. This is largely unknown and has not yet been evaluated; however, the degradative properties of UV light on plastics and other materials are widely recognised [55] .
nm violet-blue light
More recently, the germicidal properties of violet-blue visible light wavelengths have been demonstrated, and the enhanced safety of these wavelengths compared to UV light are paving the way for its exploitation as an alternative lightbased environmental decontamination technology.
The high-intensity narrow-spectrum (HINS) light environmental decontamination system (EDS) is a visible light-based system which uses low-irradiance violet-blue light, focused on 405 nm, to provide continuous environmental decontamination, a technology that was recently reviewed [56••] . Unlike, UVC and chemical-based systems, the EDS is designed for use in occupied posed surfaces in occupied environments.
Although not yet commercially available, this user-friendly, ceiling-mounted light source has been evaluated within clinical environments with successful results [57] [58] [59] .
Studies have investigated use of the system within occupied isolation rooms, and results generated from the collection of environmental samples before, during and after use of this technology have provided significant evidence of the efficacy of this system for reducing environmental bioburden around isolation rooms. Studies carried out in an occupied ICU isolation room, demonstrated evidence of the efficacy of the EDS, with a significant 60 to 70 % reductions in both the total viable bacterial counts (TVC) and the staphylococcal bioburden around the environment, over and above the reductions achieved by cleaning alone, with the EDS achieving an almost uniform reduction in bioburden across the room surfaces [59] . Studies conducted in Burns Unit isolation rooms also demonstrated the efficacy of the system, with 56-86 % reductions in staphylococcal contamination on surfaces around isolation rooms occupied by MRSA positive patients and up to 90 % reduction of contamination after 24 h use in an unoccupied room [57] . Further confirmation of the effectiveness of the system was obtained by switching off the EDS and observing that bacterial contamination levels increased and returned to around pretreatment levels when operation of the system ceased. In addition to its use for disinfection of occupied isolation rooms, a study by Bache et al. [58] demonstrated the efficacy of the system for decontamination of a Burns outpatient clinic, with a 61 % efficacy achieved. Results have also demonstrated its efficacy for significantly reducing the environmental microbial contamination of non-patient environments including a nurses' changing area [60] .
The antimicrobial action of 405 nm violet-blue light is caused by oxidative damage resulting from the photoexcitation of porphyrin molecules within exposed microorganisms, and antimicrobial activity is broad, affecting a wide range of clinically relevant organisms, including MRSA, C. difficile and A. baumannii [61] . Bacteria, bacterial biofilms, fungi, yeast and bacterial endospores are all susceptible to inactivation; however, as expected, bacterial spores display resilience and require significant doses of light to initiate inactivation [62] [63] [64] . The virucidal effects of this technology are also not fully determined; however, initial studies using bacteriophage highlight that inactivation is possible; however, as with the spores, higher light doses are required [65] .
As mentioned, a major benefit of this technology is that it can be used safely within occupied environments, and this is due to the use of visible light wavelengths, with a lower photon energy than that of UVC light. However, with this benefit, comes the inherent limitation that inactivation using this lowirradiance light is much slower than that of UVC light, requiring exposure times in the order of hours [66] rather than minutes, as is the case with most of the UV and chemical-based systems. This however, means that the system is optimally deployed for continuous decontamination where it can continuously impact on the release of microbial pathogens associated with major bioburden dispersal activities such as bandage changing and bed-making [67•] , rather than for intense, short-time terminal cleaning. An additional benefit resulting from the use of these longer, lower energy photons, is that there will be significantly less material degradation compared to the UV and chemical-based systems [55] .
Conclusions
HAI resulting from cross-transmission of infectious organisms from the environment is an area gaining increased recognition, and with the appropriate level of patient care and enhanced environmental cleaning, rates of these infections from environmental sources have the potential to be minimised. For various reasons, ranging from staff time constraints to the fact that not all surfaces around the patient environment are regularly cleaned, a new range of technologies are emerging which focus on providing decontamination of the 'whole-room' environment. This review has described a range of both chemical-based and light-based 'whole-room' decontamination technologies, including hydrogen peroxide, chlorine dioxide, ozone, steam, UV light and violet-blue light. These technologies each present benefits, ranging from rapid action to the safe decontamination of occupied patient areas; however, each technology also has limitations which need to be taken into consideration before implementation.
Although these technologies are being developed for providing enhanced environmental hygiene, they are not a replacement for traditional disinfectantbased cleaning, and it is extremely important that cleaning and infection control procedures are still maintained to the highest standard. For a number of these technologies, efficacy is significantly reduced if there is biological soiling or debris present on surfaces [68, 69] , therefore reinforcing the strict requirement for traditional cleaning, even when used in combination with new technologies, and these considerations will be very important during the uptake of these technologies.
Overall, there is unlikely to be a single solution to ensuring the cleanest possible patient environment, but the best method is likely to involve complementary use of a number of strategies. For example, the use of routine disinfectant cleaning could be supplemented by use of violet-blue light for continuous room decontamination and chemical or UV light-based terminal cleans, thus providing effective decontamination before, during and after the patient stay. This type of multi-faceted decontamination strategy, coupled with optimal hand hygiene compliance, is currently likely to be the best way forward for improved environmental decontamination and reducing the risk of patients contracting an HAI from environmental sources.
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